Mental health, sleep, and respiratory health after initiating elexacaftor/tezacaftor/ivacaftor treatment in children with cystic fibrosis.

Hiep PhamMoya VandeleurRheanna M MainzerSarath Ranganathan

Published in: Pediatric pulmonology (2024)

This is the first prospective longitudinal study of mental health and sleep changes after ETI commencement in adolescents with CF. Although respiratory outcomes improved, ETI did not improve anxiety, depression or sleep.

Keyphrases

mental health
sleep quality
physical activity
cystic fibrosis
young adults
depressive symptoms
mental illness
public health
healthcare
respiratory tract
risk assessment
metabolic syndrome
weight loss
insulin resistance
replacement therapy
health promotion
social media